Oncology biomarker testing in precision medicine — the molecular profiling of tumors to match patients with targeted therapies, immunotherapies, and clinical trials representing the largest and fastest-growing application segment — creates the most clinically transformative market opportunity, with the Precision Medicine Market reflecting oncology biomarker testing as the premium...